CM-675
CAS No. 1872466-47-1
CM-675 ( CM675;CM 675 )
产品货号. M12901 CAS No. 1872466-47-1
CM-675 (CM675) is a potent, dual PDE5 and classI-HDAC inhibitor with IC50 of 114/673 nM for PDE5A/HDAC1, respectively.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥1183 | 有现货 |
|
5MG | ¥2001 | 有现货 |
|
10MG | ¥3216 | 有现货 |
|
25MG | ¥5370 | 有现货 |
|
50MG | ¥7655 | 有现货 |
|
100MG | ¥10368 | 有现货 |
|
200MG | 获取报价 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称CM-675
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述CM-675 (CM675) is a potent, dual PDE5 and classI-HDAC inhibitor with IC50 of 114/673 nM for PDE5A/HDAC1, respectively.
-
产品描述CM-675 (CM675) is a potent, dual PDE5 and classI-HDAC inhibitor with IC50 of 114/673 nM for PDE5A/HDAC1, respectively; displays >10-fold selectivity over HDAC6; induces significant cellular responses (AcH3K9 and pCREB) at low concentrations (26-100 nM) with little cytotoxicity; shows an adequate ADME-Tox profile and in vivo target engagement (histone acetylation and cAMP/cGMP response element-binding (CREB) phosphorylation) in the central nervous system (CNS).
-
同义词CM675;CM 675
-
通路Cell Cycle/DNA Damage
-
靶点HDAC
-
受体HDAC
-
研究领域——
-
适应症——
化学信息
-
CAS Number1872466-47-1
-
分子量536.64
-
分子式C31H32N6O3
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)CC4=CC=C(C=C4)C(=O)NC5=CC=CC=C5N)OCC)C
-
化学全称N-(2-aminophenyl)-4-[[4-ethoxy-3-(1-methyl-7-oxo-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-5-yl)phenyl]methyl]benzamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Rabal O, et al. ACS Chem Neurosci. 2018 Dec 10. doi: 10.1021/acschemneuro.8b00648.
产品手册
关联产品
-
Class I and IIB HDAC...
Class I and IIB HDAC inhibitor 42 is a novel potent, selective class I and IIB inhibitor.
-
NCC-149
A potent and selective HDAC8 inhibitor with IC50 of 70 nM.
-
SIS17
SIS17 is a potent and selective HDAC 11 inhibitor with an IC50 value of 0.83 μM. SIS17 is active in cells and inhibited the demyristoylation of a known HDAC11 substrate serine hydroxymethyl transferase 2 without inhibiting other HDACs.